Clinical trial
Chinese Medicine WT for Elevating IGF-1 of Patients With Spinocerebellar Ataxia Type 3 - Pilot Study
NCT05038306 is registered in ClinicalTrials.gov with Changhua Christian Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chinese Medicine WT for Elevating IGF-1 of Patients With Spinocerebellar Ataxia Type 3 - Pilot Study
- Lead sponsor
- Changhua Christian Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2021
- Completion date
- September 26, 2022
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ataxia, spinocerebellar, insulin-like growth factor i, medicine, chinese traditional